Metraipolis › archive › dc_fca0ba39952b

Reversed phase HPLC analysis of mobocertinib and its impurities and studies on the structure and biological activity of a new degradation product — Europe PMC PMID:41059051

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41059051
DOI
10.3389/fchem.2025.1659507
License (as archived)
solo-consultazione
Archived
2026-11-09T19:59:36.562Z
SHA-256 of the archived text
ecceb7f655ba4d6a05062ce629969cc61c3cd7f001a822fa4cf9ee4c70c99e3e
Stable URL of this page
https://metraipolis.com/documento/dc_fca0ba39952b

How to cite

Reversed phase HPLC analysis of mobocertinib and its impurities and studies on the structure and biological activity of a new degradation product — Europe PMC PMID:41059051 — Europe PMC (en), https://europepmc.org/article/MED/41059051 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fca0ba39952b (Metraipolis archive dc_fca0ba39952b, sha256 ecceb7f655ba4d6a05062ce629969cc61c3cd7f001a822fa4cf9ee4c70c99e3e)
BibTeX
@misc{dcfca0ba39952b,
  title = {Reversed phase HPLC analysis of mobocertinib and its impurities and studies on the structure and biological activity of a new degradation product — Europe PMC PMID:41059051},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41059051},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fca0ba39952b; sha256 ecceb7f655ba4d6a05062ce629969cc61c3cd7f001a822fa4cf9ee4c70c99e3e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41059051. Agents can read the archived copy with the MCP tool read_document.